Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility

Clinical trial NCT04244877 · WITHDRAWN

Trial details

NCT number: NCT04244877
Sponsor: MetroHealth Medical Center
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Cirrhosis, Liver Minimal Hepatic Encephalopathy Small Intestinal Bacterial Overgrowth Gastrointestinal Motility Disorder

Start date: 2021-09-15
Primary completion: 2023-05-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.